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Sir —I write this letter to point out a grave error in the paper 
entitled “Outcome of the cementless Taperloc stem: a compre-
hensive literature review including arthroplasty register data” 
(Labek et al. 2011).
The paper incorrectly identifies Richard Rothman as the 
designer of the Taperloc femoral component. In fact, the 
developer of the Taperloc stem was William Kennedy at the 
hip and knee center in Oshkosh, WI. Therefore, the paper’s 
conclusion that “the excellent results published by the devel-
oper’s clinic are generally not reproducible by other surgeons” 
is invalid. The 4 articles authored by McLaughlin and Lee 
referenced in this paper present the rate of revision of the 
Taperloc stem from the center where the Taperloc originated. 
The only 4 articles authored by a Taperloc developer are the 
4 from McLaughlin et al. The differences in revision rates for 
the Taperloc as published by McLaughlin and Lee versus the 
other (non-developing) authors, as well as for McLaughlin 
and Lee versus the registry data are both within a factor 3 and 
thus are not clinically relevant per the criterion used by Labek 
et al. to define outlier datasets. If this paper had correctly iden-
tified the designer of the Taperloc their conclusion would have 
been: Studies originating from the center where the Taperloc 
stem was developed accurately reflect the data published from 
other centers as well as registry data.
Jeffrey R. McLaughlin, M.D.
Medical Director
Kennedy Center for the Hip and Knee, Mercy Medical Center
2700 W Ninth Ave Suite 125, Oshkosh, WI  54904
mjohnson@KCHipandknee.com
Sir —The study had clear inclusion criteria for the identifica-
tion of inventors, which are mentioned in the paper according 
to regular scientific procedures: (Co-)Authorship and refer-
ence to the affiliation by the manufacturer of the implant and/
or in peer reviewed, Medline-listed publications. 
We were aware of Dr. Kennedy’s contribution through a 
Biomet/Rothman paper from 1995, which indicates Dr. Ken-
nedy’s affiliation as “Kennedy Center for Hip and Knee, 
Neenah, WI”.
Since Dr. Kennedy was not listed as (co-)author of the 
papers identified, since the affiliation was not identical, and 
since Biomet did not make reference to Dr. Kennedy or Dr. 
McLaughlin on their website or documents, we were not able 
to include these papers according to the inclusion criteria.
Dr. Rothman in contrast was mentioned as inventor by the 
manufacturer. Biomet deleted these references from their web 
page (without substitution by Dr. Kennedy or Dr. McLaughlin, 
who claims to be inventor on his web page, too). I have no 
detailed information whether this was due to the fact that we 
raised critical questions at that time, or due to the fact that Dr. 
Rothman was centrally involved in the design of a very similar 
stem (Accolade) for a Biomet competitor (Stryker).
In his letter (and on the website of the Kennedy Center) Dr. 
McLaughlin speaks of a close cooperation with Dr. Kennedy. 
The average follow-up of the patients included in the publica-
tions referenced in our paper is longer than Dr. McLaughlin’s 
affiliation to the Kennedy Center. In my view it is remark-
able that Dr. Kennedy was not co-author of the publications 
although Dr. McLaughlin claims the contribution now.
For these reasons I cannot accept the statement that publica-
tions by McLaughlin and Lee are the only articles “authored 
by the Taperloc developers”, the main statement of the letter.
I would like to propose to respect the basic attitude at least 
in European Journals not to mix up marketing and science.
Some final comments to Dr. McLaughlin:
I have checked the Kennedy Center’s website.
My congratulations on the outcome results published there 
(<1% Revision rate for Taperloc after 26 years; A ratio of 15 
to Register data and a ratio of almost 10 to the previous papers 
published by him). Although the published revision rate only 
seems to include aseptic loosening, a remarkable difference 
remains since in worldwide Register data more than 55% of 
all revisions in THA are due to aseptic loosening.
The alternative hypothesis (Oshkosh produces a large 
number of revisions that are to a higher extent due to reasons 
related to the surgeons, like dislocation or septic complica-
tions) appears quite unlikely, since Dr. McLaughlin seems to 
be very proud of his surgical skills, which is supported by the 
revision rates mentioned for TKA. It corresponds to 24.6% 
of the average worldwide Revision rate in Registers (ratio: 
4.06). Since the USA do not run a National arthroplasty Reg-
ister, national data are not included, but the difference to the 
national average should be even higher due to the higher aver-
age revision rates/revision burden in the USA compared to 
other developed countries.
For THA the average revision rate in the USA is double 
compared to Sweden.634  Acta Orthopaedica 2011; 82 (5): 633–634
Against this background, I suppose the reference to “Ken-
nedy Center’s world-class care” and “the most successful tita-
nium hip replacement in the world” might be justified. 
Anyhow, this letter to the editor is a nice example in support 
of the original paper focusing on transparency and reliability 
of published outcome data in health care. 
Gerold Labek, M.D
Department of Orthopaedics, Innsbruck Medical University, 
Innsbruck, Austria
gerold.labek@efort.org
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